Nebilet®
(nebivolol hydrochloride)

Patient Adherence Program

Program overview

This sponsored program aims to provide education and support to patients prescribed Nebilet® for the treatment of chronic heart failure.

The program consists of a series of 12 messages delivered over 10 months, with information and topics focused on the quality use of medicines and improving medication adherence and treatment outcomes for patients.

When?

From 15 February 2024

For which patients?

Program messages will be delivered via app/email or SMS to patients who are signed up to MedAdvisor and dispensed Nebilet®.

View messages

Click here to view a sample of the messages or go to the Digital Adherence Program tile in the PlusOne Health Services Hub to learn more.

Nebilet image